
Mirae Asset Capital
Asia, Seoul-t'ukpyolsi, South Korea, Seoul'%3e%3cg id='b'%3e%3cpath id='a' stroke='%23000' stroke-width='2' d='M-6-25H6m-12 3H6m-12 3H6'/%3e%3cuse xlink:href='%23a' y='44'/%3e%3c/g%3e%3cpath stroke='%23fff' d='M0 17v10'/%3e%3ccircle r='12' fill='%23cd2e3a'/%3e%3cpath fill='%230047a0' d='M0-12A6 6 0 0 0 0 0a6 6 0 0 1 0 12 12 12 0 0 1 0-24z'/%3e%3c/g%3e%3cg transform='rotate(-123.69)'%3e%3cuse xlink:href='%23b'/%3e%3cpath stroke='%23fff' d='M0-23.5v3M0 17v3.5m0 3v3'/%3e%3c/g%3e%3c/svg%3e)
Description
South Korean investment firm, headquartered in Seoul.
Investor Profile
Mirae Asset Capital has made 49 investments, with 10 in the past 12 months and 12% as lead.
Stage Focus
- Series B (41%)
- Series C (18%)
- Series A (16%)
- Series D (8%)
- Series Unknown (6%)
- Seed (6%)
- Series E (2%)
- Convertible Note (2%)
Country Focus
- United States (53%)
- South Korea (39%)
- Germany (2%)
- Hong Kong (2%)
- India (2%)
- France (2%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Information Technology
- Artificial Intelligence (Ai)
- Software
- Pharmaceutical
- Therapeutics
- E-commerce
- Marketplace
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.